The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca’s Breakthrough Therapy Designation, 3 IPOs – Yahoo Finance

Here’s a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 1)

• 10X Genomics Inc (NASDAQ: TXG)
• AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) ( moved on M&A speculation)
• Annexon Inc (NASDAQ: ANNX)
• Axonics Modulation Technologies Inc (NASDAQ: AXNX)
• Beigene Ltd (NASDAQ: BGNE)
• BioLife Solutions Inc (NASDAQ: BLFS) (closed SciSafe buy)
• Blueprint Medic…

  Click here to view the original article.